Why the study?
Do regimen adherence problems affect clinical INR range and encounter time in a pharmacist-directed anticoagulation management service?
Do regimen adherence problems affect clinical INR range and encounter time in a pharmacist-directed anticoagulation management service?
Regimen adherence problems significantly negatively impact both clinical outcomes (INR control) and operational efficiency (encounter time) in pharmacist-directed anticoagulation clinics.
Answers are grounded in this paper and cite their sources.
Supports adherence assessment in anticoagulation clinics; leaves open whether targeted interventions improve INR control or efficiency.
The purpose of this study was to use a performance-driven organizational change framework to measure both the clinical performance and time performance of a pharmacist-directed anticoagulation management service. A sample of 286 consecutive encounters between patients and anticoagulation management service staff was selected over a 2-month period at the anticoagulation management service of a midwestern university medical center. Data were analyzed using descriptive statistics, logistic regression, and linear regression analysis. Regression-based estimates documented that patients with at least one regimen adherence problem were approximately 10 times more likely to be outside their clinical INR range (clinical performance issue) and required an average of 4 minutes more per encounter (time performance issue) compared with patients who exhibited no adherence problems. Performance metrics such as clinical and time performance can be useful for organizational adaptation and organizational growth decisions related to an anticoagulation management service.
No takes yet. Share an insight, caveat, or question.
Schommer et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: